Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Circulation Research

• Publication date

  1992-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.RES.70.4.856PMID 1551208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

  1991cited by this paper
• Myosin-induced acute myocarditis is a T cell-mediated disease.

  1991cited by this paper
• Neutrophil influx into an inflammatory site inhibited by a soluble homing receptor–IgG chimaera

  1991cited by this paper
• LPS promotes CB3-induced myocarditis in resistant B10.A mice.

  1991cited by this paper
• MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.

  1990cited by this paper
• An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

  1990cited by this paper
• cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line

  1990cited by this paper
• IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1.

  1990cited by this paper
• Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

  1990cited by this paper
• CDw18 Dependent Adhesion of Leukocytes to Endothelium and Its Relevance for Cardiac Reperfusion

  1990cited by this paper
• An analysis of the role of tumor necrosis factor in the phenotypic expression of actively induced experimental allergic orchitis and experimental allergic encephalomyelitis.

  1990cited by this paper
• Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

  1990cited by this paper
• T-cell responses and immunity to experimental infection with leishmania major.

  1989cited by this paper
• Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.

  1989cited by this paper
• Regulation of T‐Cell Activation; Differences among T‐Cell Subsets

  1989cited by this paper
• Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

  1989cited by this paper
• Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.

  1989cited by this paper
• Adhesion molecules controlling lymphocyte migration.

  1989cited by this paper
• Interferon‐γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I‐Aβ, tumor necrosis factor and complement component C3 in mouse macrophages

  1989cited by this paper
• Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

  1989cited by this paper
• The biology of cachectin/TNF--a primary mediator of the host response.

  1989cited by this paper
• Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages.

  1989cited by this paper
• Mechanism of Complement Activation After Coronary Artery Occlusion: Evidence That Myocardial Ischemia in Dogs Causes Release of Constituents of Myocardial Subcellular Origin That Complex With Human C1q In Vivo

  1988cited by this paper
• Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression.

  1988cited by this paper
• Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma.

  1988cited by this paper
• Cooperative effect of interferon‐γ and tumor necrosis factor‐α on the induction of the class II antigen‐associated invariant chain expression

  1988cited by this paper
• Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells.

  1988cited by this paper
• Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons

  1988cited by this paper
• Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis

  1988cited by this paper
• Effects of tumor necrosis factor on the interferon‐γ‐induced major histocompatibility complex class II antigen expression by human endothelial cells

  1988cited by this paper
• Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.

  1988cited by this paper
• Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.

  1988cited by this paper
• Role of neutrophils in ischemia-reperfusion-induced microvascular injury.

  1987cited by this paper
• Cardiac myosin induces myocarditis in genetically predisposed mice.

  1987cited by this paper
• Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.

  1987cited by this paper
• Myocarditis. A histopathologic definition and classification.

  1987cited by this paper
• Noncytocidal mechanisms of action of tumor necrosis factor-alpha on human tumor cells: enhancement of HLA gene expression synergistic with interferon-gamma.

  1986cited by this paper
• Noncytocidal Mechanisms of Action of Tumor Necrosis Factor-α on Human Tumor Cells: Enhancement of HLA Gene Expression Synergistic with Interferon-γ*

  1986cited by this paper
• Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro.

  1986cited by this paper
• Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

  1986cited by this paper
• Selective Accumulation of the First Component of Complement and Leukocytes in Ischemic Canine Heart Muscle: A Possible Initiator of an Extra Myocardial Mechanism of Ischemic Injury

  1985cited by this paper
• Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.

  1985cited by this paper
• Lymphocyte specificity to protein antigens. II. Fine specificity of T- cell activation with cytochrome c and derived peptides as antigenic probes

  1979cited by this paper
• Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.

  1975cited by this paper
• Antibody-independent activation of human C1 after interaction with heart subcellular membranes.

  1973cited by this paper
• Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor ( TNF ) : Similarities between TNF-a and interleukin 1 ( insulitis / adoptive transfer / Ia expression / autoimmune disease ) CHAIM 0

  year unknowncited by this paper

• Role of T Cells in Viral and Immune-mediated Myocarditis

  2024cites this paper
• TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells

  2023cites this paper
• Modulation of TLR4/NFκB Pathways in Autoimmune Myocarditis

  2023cites this paper
• Could ARNI have an Effect on LV Fibrosis and Inflammatory Parameters in an Experimental Autoimmune Myocarditis Model?

  2022cites this paper
• Transcriptomic Analysis of Inflammatory Cardiomyopathy Identifies Molecular Signatures of Disease and Informs in silico Prediction of a Network-Based Rationale for Therapy

  2021cites this paper
• Complexity of TNF-α Signaling in Heart Disease

  2020cites this paper
• Literature review: The role of inflammatory biomarkers in the connections between sleep and chronic health conditions

  2020cites this paper
• Myocarditis in Humans and in Experimental Animal Models

  2019cites this paper
• Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice

  2018cites this paper
• Chapter 1 - Cellular Immunity: A Role for Cytokines

  2017cites this paper
• Cytoplasmic Proteins as Autoantigens in the Development of Inflammatory Heart Disease

  2017influential citation
• Oleuropein prevents the development of experimental autoimmune myocarditis in rats

  2017cites this paper
• Absence of nonhematopoietic MHC class II expression protects mice from experimental autoimmune myocarditis

  2016cites this paper
• Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice

  2016cites this paper
• Phosphoinositide 3-kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice.

  2016cites this paper
• Viral Infection and Heart Disease: Autoimmune Mechanisms

  2015cites this paper
• Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditis

  2014cites this paper
• The Clinical and Diagnostic Significance of Anti-myosin Autoantibodies in Cardiac Disease

  2013cites this paper
• Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy

  2013influential citation
• Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats.

  2012cites this paper
• Emodin, a naturally occurring anthraquinone, ameliorates experimental autoimmune myocarditis in rats.

  2012cites this paper
• Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis.

  2011influential citation
• Quercetin ameliorates experimental autoimmune myocarditis in rats.

  2010cites this paper
• Role of Tumour Necrosis Factor Alpha (TNFa) in ischaemic and pharmacological postconditioning

  2010cites this paper
• Autoimmune Murine Myocarditis and Immunomodulatory Interventions

  2010cites this paper
• Oral Tolerization with Cardiac Myosin Peptide (614–629) Ameliorates Experimental Autoimmune Myocarditis: Role of Stat 6 Genes in BALB/CJ Mice

  2009cites this paper
• AFECCIÓN CARDÍACA EN LA INFECCIÓN POR VIRUS DE LA INMUNODEFICIENCIA HUMANA TIPO 1

  2008cites this paper
• Endothelial dysfunction in normal and abnormal glucose metabolism.

  2008cites this paper
• Beneficial effects of dimethyl fumarate on experimental autoimmune myocarditis.

  2008cites this paper
• Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.

  2007cites this paper
• Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-alpha is rescued by HDAC inhibitor trichostatin A.

  2007cites this paper
• Interferon- (cid:1) Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice

  2007cites this paper
• Inflammationsreaktion und myokardiale Funktion nach kardiochirurgischen Eingriffen im Kindesalter

  2007cites this paper
• Fusidin ameliorates experimental autoimmune myocarditis in rats by inhibiting TNF-alpha production.

  2007cites this paper
• Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts

  2007cites this paper
• Diagnosis and management of viral myocarditis

  2007cites this paper
• Endothelial dysfunction: a comprehensive appraisal

  2006cites this paper
• Inflammatory cardiomyopathy: there is a specific matrix destruction in the course of the disease.

  2006cites this paper
• Protecting the pump: controlling myocardial inflammatory responses.

  2006cites this paper
• The significance of autoimmunity in myocarditis.

  2006cites this paper
• National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy.

  2006cites this paper
• Giant Cell Myocarditis

  2005cites this paper
• [Ca2']j and Cell Contraction in Cultured Chick Ventricular Myocytes

  2005cites this paper
• Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus‐induced myocarditis

  2005cites this paper
• Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure.

  2005cites this paper
• Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.

  2004cites this paper
• Rheumatic Heart Disease Proinflammatory Cytokines Play a Role in the Progression and Maintenance of Valvular Lesions

  2004influential citation
• The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis.

  2004cites this paper
• Mast Cells and Innate Cytokines are Associated with Susceptibility to Autoimmune Heart Disease Following Coxsackievirus B3 Infection

  2004cites this paper
• Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes.

  2003cites this paper
• The inflammatory process in experimental myocarditis

  2003cites this paper
• Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes.

  2003cites this paper
• Animal Models of Autoimmune Myocarditis

  2003cites this paper
• Cellular Immunity: A Role for Cytokines

  2003cites this paper
• Effect of mechanical assist devices for ischemic myocardial damage-cardiomyocyte apoptosis and TNFalpha-.

  2003cites this paper
• Inflammation and Cardiac Diseases

  2003cites this paper
• Stress-activated cytokines and the heart: from adaptation to maladaptation.

  2003cites this paper
• Myocardit is-inducing Epitope o f Myosin Binds Constitutively and Stably to I-A k on Antigen-present ing Cells in the Heart

  2003cites this paper
• Innovative drug treatments for viral and autoimmune myocarditis.

  2002cites this paper
• Lipopolysaccharide administration increases acid and alkaline phosphatase reactivity in the cardiac muscle

  2002cites this paper
• Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis.

  2002cites this paper
• Levels of MCP-1 and GM-CSF mRNA Correlated with Inflammatory Cytokines mRNA Levels in Experimental Autoimmune Myocarditis in Rats

  2002cites this paper
• Tumour necrosis factor α gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?

  2002cites this paper
• Mechanism of cardioprotective action of TNF-alpha in the isolated rat heart.

  2002cites this paper
• Immune mediators in inflammatory heart disease: insights from a mouse model

  2002cites this paper
• Cardiomyopathy is linked to complement activation.

  2002cites this paper
• Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease.

  2002cites this paper
• Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease

  2002cites this paper
• Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

  2001cites this paper
• Prevention of Autoimmune Myocarditis Through the Induction of Antigen-Specific Peripheral Immune Tolerance

  2001cites this paper
• Interleukin-12 Receptor/STAT4 Signaling Is Required for the Development of Autoimmune Myocarditis in Mice by an Interferon-&ggr;–Independent Pathway

  2001cites this paper
• Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses.

  2001cites this paper
• Mice : A Study Using Mice Lacking TNF-) Plays a Protective Role in Acute Viral Myocarditis in α ( TNF-α Tumor Necrosis Factor

  2001cites this paper
• Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha.

  2001cites this paper
• Changes in calcium cycling precede cardiac dysfunction during autoimmune myocarditis in mice.

  2001cites this paper
• Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines.

  2001cites this paper
• Growth hormone interferes with the progression of myocarditis in rats.

  2001cites this paper
• FR167653 suppresses the progression of experimental autoimmune myocarditis

  2001cites this paper
• The effect of intravenous immunoglobulins on the progression of experimental autoimmune myocarditis in the rat.

  2001cites this paper
• Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.

  2001cites this paper
• Pathophysiological role of cytokines in congestive heart failure.

  2001cites this paper
• Neurohormones, Cytokines and Programmed Cell Death in Heart Failure: A New Paradigm for the Remodeling Heart

  2001cites this paper
• The Transition from Viral to Autoimmune Myocarditis

  2001cites this paper
• Cellular and molecular basis of inflammatory myocardial disease

  2001cites this paper
• The role of tumor necrosis factor in cardiac disease.

  2001cites this paper
• Tumor Necrosis Factor-α (TNF-α) Plays a Protective Role in Acute Viral Myocarditis in Mice

  2001cites this paper
• Tumor Necrosis Factor- a (TNF- a ) Plays a Protective Role in Acute Viral Myocarditis in Mice A Study Using Mice Lacking TNF- a

  2001cites this paper
• Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway.

  2001cites this paper
• Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change.

  2000cites this paper
• Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice.

  2000cites this paper
• Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy.

  2000cites this paper
• Use of targeted anticytokine treatments in heart failure.

  2000cites this paper
• Giant cell myocarditis: most fatal of autoimmune diseases.

  2000cites this paper
• Alterations in cardiac function and gene expression during autoimmune myocarditis in mice.

  2000cites this paper
• From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease.

  2000cites this paper
• Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis.

  2000cites this paper
• Influence of myocarditis on left ventricular function.

  2000cites this paper
• TNF-α and Heart Failure The Difference Between Proof of Principle and Hypothesis Testing

  1999cites this paper
• Genetic control of autoimmune myocarditis mediated by myosin-specific antibodies

  1999cites this paper
• Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.

  1999cites this paper